While some speculate on her use of Ozempic, Selenas journey is better understood through her focus on overall wellness
Beyond T2D and weight management in individuals with overweight or obesity, GLP-1 receptor agonists are approved for metabolic dysfunction associated steatohepatitis in people with moderate or advanced fibrosis, obstructive sleep apnea in obese adults, reduction of major adverse cardiovascular events in adults with T2D and cardiovascular disease (CVD), and slowing progression of chronic kidney disease and cardiovascular mortality in adults with both chronic kidney disease and T2D
Participants following semaglutide alongside a reduced-calorie diet and exercise program lost an average of approximately 14.9% of body weight, compared to approximately 2.4% in the placebo group
Ozempic and Semaglutide are brand names for semaglutide, a GLP-1 receptor agonist that mimics the hormone glucagon-like peptide-1 to regulate blood glucose, suppress appetite, and slow gastric emptying
Most patients can safely continue GLP-1 medications before colonoscopy with appropriate precautions, including a 24-hour liquid-only diet before the procedure